ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 457

Levels of Satisfaction with RA Treatment and Associated Alignment between Rheumatologists and Their Patients across Latin America

Enrique R Soriano1, José Antonio Maldonado-Cocco2, David Vega-Morales3, Diana Rocio Gil4, Ivanio Pereira5, Generoso Guerra6, Wilson Bautista-Molano7, Julio Casasola8, Valderilio F Azevedo9, Leandro Aldunate10 and Steve Lobosco11, 1Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, CABA, Argentina, 2Buenos Aires University, Consulting Professor of Rheumatology, Buenos Aires University. Argentina, Buenos Aires, Argentina, 3Universidad Autónoma de Nuevo León. Rheumatology Service, Internal Medicine Department, Hospital Universitario "Dr. José Eleuterio González". Mexico, Monterrey, Mexico, 4ART Medica - Hospital Universitario Mayor MEDERI Internal Medicine and Rheumatology. Colombia., Bogota, Colombia, 5Rheumatology, Universidade Federal de Santa Catarina, Hospital Universitário, Divisão de Reumatologia.Brazil, Florianopolis, Brazil, 6Centro Médico Paitilla Internal Medicine and Rheumatology Department. Panama, Panama City, Panama, 7School of Medicine, Universidad Militar Nueva Granada and Rheumatology Department Hospital Militar. Colombia, Bogotá, Colombia, 8Rheumatology, Hospital General de Mexico, Mexico, Mexico, 9Adjunct Professor of Rheumatology, Federal University of Paraná; Brazil, Curitiba, Brazil, 10Immunology, Janssen Latin America, Buenos Aires, Argentina, 11Adelphi, Immunology Director- Adelphi Group, Manchester, United Kingdom

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster I: Treatment Patterns and Response

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: To assess levels of rheumatologist and patient satisfaction with RA treatment across Latin America and any disconnects that may exist between the two in real world clinical practice.

Methods: Data from the 2015 RA Disease Specific Programme (DSP), a cross-sectional, multi-national survey of patients and rheumatologists conducted in Argentina, Mexico, Colombia and Venezuela were analyzed. Rheumatologists (n=141) completed forms containing patient demographics, patient disease severity and treatment satisfaction. Patients self-reported their level of treatment satisfaction and disease severity.

Results: A total of 555 RA patients from across Latin America were included in this analysis. Current mean age across Latin America was 51.9 years and 82.3% female. Proportions of rheumatologists and patients reporting satisfaction with treatment were statistically highly similar (79% and 83% respectively), however current disease severity reporting differed between rheumatologists and patients (mild 70% / moderate-severe 30% rheumatologists vs. 51% mild / 49% moderate-severe patients; p<0.001). When assessed for alignment, 21% of rheumatologists and patients disagreed on the level of satisfaction, driven mainly by rheumatologists over-stating dissatisfaction (13%) vs. their patient (8%) (p=0.031). For current disease severity, 36% of rheumatologists and patients disagreed, driven mainly by patients (28%) over-stating their severity vs. their rheumatologist (8%) (p<0.001). Of those patients for whom their rheumatologist was satisfied with treatment, 20% were classified as having moderate to severe RA by that same physician.

Conclusion: Despite many rheumatologists and their patients in Latin America reporting high levels of satisfaction with treatment, patients frequently remain moderate to severe and disconnected from their physician. There is a need to improve physician / patient engagement as a means to improving clinical control.


Disclosure: E. R. Soriano, AbbVie, Janssen, Novartis, Pfizer Inc, UCB, 2,AbbVie, Janssen, Novartis, Pfizer Inc, UCB, 5,AbbVie, Bristol-Myers Squibb, Janssen, Novartis, Pfizer Inc, Roche, UCB, 8; J. A. Maldonado-Cocco, None; D. Vega-Morales, None; D. Rocio Gil, None; I. Pereira, None; G. Guerra, None; W. Bautista-Molano, None; J. Casasola, None; V. F. Azevedo, AbbVie, Eli Lilly, Genentech, GSK, Pfizer Inc, UCB, 2,AbbVie, Merck-Serono, Novartis, Pfizer Inc, 5,AbbVie, Janssen, Merck-Serono, Novartis, Pfizer Inc, Sanofi, 8; L. Aldunate, Janssen Pharmaceutica Product, L.P., 3; S. Lobosco, Adelphi, 3.

To cite this abstract in AMA style:

Soriano ER, Maldonado-Cocco JA, Vega-Morales D, Rocio Gil D, Pereira I, Guerra G, Bautista-Molano W, Casasola J, Azevedo VF, Aldunate L, Lobosco S. Levels of Satisfaction with RA Treatment and Associated Alignment between Rheumatologists and Their Patients across Latin America [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/levels-of-satisfaction-with-ra-treatment-and-associated-alignment-between-rheumatologists-and-their-patients-across-latin-america/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/levels-of-satisfaction-with-ra-treatment-and-associated-alignment-between-rheumatologists-and-their-patients-across-latin-america/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology